Gilead Sets Price for Remdesivir

Gilead Sets Price for Remdesivir

Gilead Sciences, the biotech company based out of California that created one of the first original treatments for COVID-19, has set the price for remdesivir between $2,340 and $3,120 for a typical course treatment. While remdesivir has still yet to prove to reduce...